Keriton receives approval for its patent for Improved Express of Breast Milk
Keriton Kare is a HIPAA-compliant, fully automated solution to address the challenges related to feeding management in hospital Neonatal and Pediatric Intensive Care Units.
May 8, 2020
Congratulations to Broad Street Angels portfolio company, Keriton, for its patent approval on March 31, 2020!
Keriton Kare is a HIPAA-compliant, fully automated solution to address the challenges related to feeding management in hospital Neonatal and Pediatric Intensive Care Units.
Patent: Improved Expression of Breast Milk Via Automated Methods For Managing Pumped Breast Milk, Lactation Analytics & Patient Engagement, issued March 31, 2020 under U.S. Patent No. 10,603,418.
Previous